Skip to main content

Table 1 Characteristics of allopurinol users

From: Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes

 

All combined (%)

Allopurinol use (%)

  

Current‡

Previous‡

Total person days

3,724,768

2,053,185

1,671,583

Male gender

53.76

54.00

53.47

Age group

  ≤ 50

7.55

6.54

8.79

 51–60

12.86

11.66

14.33

 61–65

9.70

9.32

10.17

 66–70

24.00

24.68

23.16

 71–75

19.73

20.12

19.26

 76–80

14.16

14.41

13.86

  > 80

12.00

13.27

10.44

Race

 Asian

4.49

4.29

4.73

 Black

19.68

16.83

23.18

 Hispanic

2.61

2.01

3.35

 Other

1.87

1.78

1.98

 Missing

4.89

4.26

5.67

 White

66.46

70.83

61.09

Comorbidity

 Hypertension

85.57

85.35

85.85

 COPD

9.12

9.00

9.27

 Renal disease

26.11

27.71

24.14

 PVD

8.12

8.17

8.05

 Hyperlipidemia*

79.56

80.53

78.38

  1. ‡ Characteristics of individuals that contributed at least 1 person day to that column, and people could be represented in both columns, if they contributed to both current and previous allopurinol use; *Hyperlipidemia was defined as statin use or an ICD-9-CM code for hypercholesterolemia